OCSP分型对超早期动脉溶栓治疗的价值

被引：10

作者：

徐蔚海

黄一宁

高山

金征宇

张青

机构：

[1] 中国医学科学院中国协和医科大学北京协和医院

[2] 中国医学科学院中国协和医科大学北京协和医院北京

[3] 北京

来源：

中国神经精神疾病杂志 | 2003年 / 03期

关键词：

OCSP分型; 脑梗死; 动脉溶栓治疗; DSA;

D O I：

暂无

中图分类号：

R743.33 [脑栓塞];

学科分类号：

1002 ;

摘要：

目的　探讨OCSP(Oxfordshirecommunitystrokeproject)分型应用于超早期动脉溶栓治疗的价值。方法　将我院 2 7例超早期动脉溶栓患者进行OCSP分型并与血管造影 (DSA)、NIHSS评分进行比较分析。结果　以DSA为金标准 ,OCSP分型各组患者诊断的敏感度和特异度分别为完全前循环梗塞 (TACI) (87 5 % ,95 % ) ,部分前循环梗塞(PACI) (72 7% ,88 9% ) ;腔隙性梗塞 (LACI) (6 6 7% ,92 3% ) ;后循环梗塞 (POCI) (10 0 % ,10 0 % )。患者入院NIHSS评分与分型显著相关 (P =0 0 2 1)。结论　对超早期动脉溶栓患者进行OCSP分型是可行的 ,与DSA、NIHSS的一致性较好 ;但这需要由更大样本的研究来验证。

引用

页码：177 / 179

页数：3

共 9 条

[1]

European Stroke Initiative (EUSI) recommendations for stroke management. The European Stroke Initiative Writing Committee. European Journal of Neurology . 2000

[2]

Interobserver reliability of a clinical classification of acute cerebral infarction. Lindley RI,Warlow CP,Wardlaw JM,et al. Stroke . 1993

[3]

Tissueplasminogenactivatorforacuteischemicstroke.TheNationalInstituteofNeurologicalDisordersandStrokertPAStrokeStudyGroup. TheNationalInstituteofNeurologicalDisordersandStrokertPAStrokeStudyGroup. The New England Journal of Medicine . 1995

[4]

Variability of magnetic resonance angiography and computed tomography angiography in grading middle cerebral artery stenosis. Wong KS,Wynnie WM,Eisen Liang,et al. Stroke . 1996

[5]

Classfication and natural history of clinically identifible subtypes of cerebral infarction. John B,Peter S,Martin D,et al. The Lancet .

[6]

Relationship between pattern of intracranial artery abnormalities on Transcranial Doppler and Oxfordshire Community Stroke Project clinical classificantion of ischemic stroke. Mead GE,Wardlaw JM,Dennis MS,et al. Stroke . 2000

[7]

How well dose the Oxfordshire Community Stroke Preject classfication predict the size of the infarct on brain imaging. Mead GE,Lewis SC,Wardlaw JM,et al. Journal of Neurology Neurosurgery and Psychiatry . 2000

[8]

Circadian variation in ishchemic stroke subtypes. Seemant Chaturvedi,Harold P,Adams Jr,et al. Stroke . 1999

[9]

PROACT: a phase Ⅱrandomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Gregory J,Randall T,Anthony J,et al. Stroke . 1999

← 1 →